Glioma cells were transfected with small interfering RNA/overexpression plasmid against CKS2, then clone formation assay, CCK‐8, wound healing, Transwell assay, and flow cytometry were performed to detect changes in cell viability, invasiveness, and the apoptosis rate. The gene discussed is CKS2; the disease is central nervous system cancer.